CVSA vs INGR
Covista Inc. vs Ingredion — AI-powered side-by-side comparison
CVSA
Covista Inc.
57
Watch
VS
| Metric | CVSA | INGR |
| AI Score |
57
|
62
|
| Price |
$125.97
|
$104.70
|
| P/E Ratio |
16.60×
|
11.25×
|
| ROE |
17.4%
|
16.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
57.3%
|
23.7%
|
| Debt / Equity |
0.63×
|
0.39×
|
| Dividend Yield |
0.0%
|
3.1%
|
| RSI (14) |
48.4
|
57.8
|
| Beta |
0.623
|
0.606
|
| Expected Upside |
—
|
+1.6%
|
AI Committee View
Current Innellis committee reasoning for CVSA versus INGR.
INGR leads by 5 points.
INGR scores 62/100 (Buy) versus CVSA at 57/100 (Watch).
CVSA Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — current ratio of 0.82 is tight -- limited short-term liquidity cushion. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- ROE of 16.6% shows genuine earnings power backing the valuation — Value
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
- Current ratio of 0.82 is tight -- limited short-term liquidity cushion — Risk
- Bollinger bandwidth of 24.6% signals elevated volatility — Risk
INGR Committee View
60% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is revenue declining -1.4% yoy -- this is not a growth story right now. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 11.1 is inexpensive for the broad market — Value
- Dividend yield of 3.2% pays you to wait — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Revenue declining -1.4% YoY -- this is not a growth story right now — Growth
- EPS declining -10.3% YoY despite any revenue growth — Growth